CGBio’s ‘NOVOMAX FUSION’ Spine Implant Enters Japan
CGBio has entered Japan with ‘NOVOMAX FUSION,’ a spine implant based on bioactive ceramics. This marks CGBio’s first foray into the Japanese market with their spine implant products.
What Sets NOVOMAX FUSION Apart?
NOVOMAX FUSION uses BGS-7, a bioactive glass-ceramic material. This innovative material offers distinct advantages:
- Superior biocompatibility compared to traditional titanium or PEEK materials.
- Promotes easier bone growth, enhancing osteoconductivity.
- Bone fusion occurs directly on the cage’s surface, eliminating the need for bone graft materials.
Strategic Partnership with Nippon Zoki Pharmaceutical
CGBio’s partnership with Nippon Zoki Pharmaceutical reflects strategic thinking. Established in 1939 in Osaka, Nippon Zoki specializes in chronic pain medications in orthopedics and neurology. In 2024, they founded ZSpine, a distribution company for spine implants. NOVOMAX FUSION will reach the Japanese market through ZSpine.
Key Milestones Leading Up to This Launch
- PMDA Approval: In 2023, CGBio received approval from the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan.
- Supply Contract: Secured a supply contract with Nippon Zoki Pharmaceutical.
- Market Introduction: Official market introduction through ZSpine.
Future Plans for CGBio
CGBio aims to expand its reach beyond Japan by introducing next-generation products like the Excender. Their focus remains on strengthening their product portfolio with technology-driven solutions.
What Does This Mean for Spine Surgery?
NOVOMAX FUSION’s entry into Japan could impact spine surgery practices by:
- Providing a new, biocompatible alternative for cervical fusion procedures.
- Potentially reducing the need for additional bone graft materials.
- Encouraging advancements in bioactive material technologies.
Final Thoughts
CGBio’s move into the Japanese spine implant market represents a significant milestone in medical device innovation. With continued advancements and strategic partnerships, CGBio may enhance surgical outcomes and expand its presence globally. Keep an eye on their progress if you’re interested in medical technology and healthcare improvements.
By following these developments, you’ll stay informed about cutting-edge surgical technologies and market trends, which could shape future healthcare solutions.



![[South Korea] HUONS Meditech’s URO-UEMXD Expands Global Influence](https://i0.wp.com/productadvisor.com/wp-content/uploads/2024/10/huons-1.png?fit=800%2C616&ssl=1)